Rockville, Maryland — October 28, 2026 The global gout therapeutics market is projected to increase from USD 3.2 billion in 2026 to USD 6.06 billion by 2036, expanding at a compound annual growth rate (CAGR) of 6.6% over the forecast period, according to Fact.MR. The market was valued at USD 3.0 billion in 2025. Growing demand for sustained urate-lowering treatment, greater awareness of...